Guggenheim Capital’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-24,886
Closed -$580K 1728
2026
Q1
$580K Buy
24,886
+17,590
+241% +$548K ﹤0.01% 1161
2025
Q4
$323K Buy
7,296
+1,874
+35% +$105K ﹤0.01% 1488
2025
Q3
$397K Sell
5,422
-13
-0.2% -$848 ﹤0.01% 1282
2025
Q2
$333K Sell
5,435
-452
-8% -$25.2K ﹤0.01% 1362
2025
Q1
$342K Sell
5,887
-844
-13% -$53.3K ﹤0.01% 1370
2024
Q4
$359K Buy
+6,731
New +$330K ﹤0.01% 1387
2023
Q1
Sell
-7,825
Closed -$263K 1941
2022
Q4
$263K Buy
+7,825
New +$239K ﹤0.01% 1707
2022
Q3
Sell
-6,040
Closed -$210K 1944
2022
Q2
$210K Buy
6,040
+137
+2% +$5.39K ﹤0.01% 1931
2022
Q1
$307K Buy
+5,903
New +$297K ﹤0.01% 1875

Other funds holding DOCS

Guggenheim Capital's DOCS Position: Q2 2026 in Review

Guggenheim Capital sold out of Doximity (DOCS) in Q2 2026, closing a stake of 24,886 shares — an estimated $580K sold.

Guggenheim Capital first reported a position in DOCS in Q1 2022 and held it in 9 quarters. The position peaked at $580K in Q1 2026. 358 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • Guggenheim Capital reported no remaining Doximity position as of Q2 2026 after selling out during the quarter.
  • Guggenheim Capital sold 24,886 Doximity shares in Q2 2026, an estimated $580K.
  • Guggenheim Capital first reported a position in Doximity in Q1 2022 and held it in 9 quarters.
  • Guggenheim Capital's Doximity position peaked at $580K in Q1 2026.
  • 358 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.